ImmunoPrecise Antibodies Ltd. Files 6-K with SEC
Ticker: HYFT · Form: 6-K · Filed: Apr 10, 2025 · CIK: 1715925
| Field | Detail |
|---|---|
| Company | Immunoprecise Antibodies LTD. (HYFT) |
| Form Type | 6-K |
| Filed Date | Apr 10, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: sec-filing, 6-K, corporate-update
TL;DR
IPA files 6-K, incorporating previous press releases and S-8/F-3 filings. Standard update.
AI Summary
ImmunoPrecise Antibodies Ltd. filed a Form 6-K on April 10, 2025, incorporating by reference several press releases and a registration statement. The filing includes information related to its business operations and corporate filings, with its principal executive office located in Austin, Texas.
Why It Matters
This filing provides an update on ImmunoPrecise Antibodies Ltd.'s corporate activities and regulatory disclosures, which is important for investors tracking the company's compliance and operational status.
Risk Assessment
Risk Level: low — This is a routine filing (6-K) that primarily incorporates previously issued documents and registration statements, indicating no new material adverse events.
Key Players & Entities
- ImmunoPrecise Antibodies Ltd. (company) — Filer of the 6-K report
- Austin, Texas (location) — Location of principal executive office
- Form S-8 (File No. 333-256730) (document) — Registration statement incorporated by reference
- Form F-3 (File Nos. 333-273197 and 333-281312) (document) — Registration statements incorporated by reference
FAQ
What is the purpose of this Form 6-K filing?
The Form 6-K is a report of a foreign private issuer filed to provide information that the company has made or will make public, file or submit to its home country securities regulatory authorities, or send or give to its security holders. This specific filing incorporates by reference several exhibits, including press releases and registration statements.
When was this Form 6-K filed?
This Form 6-K was filed on April 10, 2025.
What is the principal executive office address for ImmunoPrecise Antibodies Ltd.?
The principal executive office is located at Industrious, 823 Congress Ave, Suite 300, Austin, Texas 78701.
Which registration statements are being updated or referenced by this filing?
Exhibit 99.5 of this Form 6-K is incorporated by reference into the Registration Statement on Form S-8 (File No. 333-256730) and Registration Statements on Form F-3 (File Nos. 333-273197 and 333-281312).
Does ImmunoPrecise Antibodies Ltd. file annual reports on Form 20-F or Form 40-F?
ImmunoPrecise Antibodies Ltd. indicates that it files annual reports under cover of Form 20-F.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on April 10, 2025 regarding ImmunoPrecise Antibodies Ltd. (HYFT).